Cargando…
Innovations in CKRT: individualized therapy with fewer complications
Continuous kidney replacement therapy (CKRT) can be a lifesaving intervention for critically ill patients; however, mortality remains high. The adaptation of existing innovations, including anti-clotting measures; cloud-computing for optimized treatment prescribing and therapy monitoring; and real-t...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376311/ https://www.ncbi.nlm.nih.gov/pubmed/32704048 http://dx.doi.org/10.1038/s41581-020-0326-1 |
_version_ | 1783562018412822528 |
---|---|
author | Szamosfalvi, Balazs Yessayan, Lenar |
author_facet | Szamosfalvi, Balazs Yessayan, Lenar |
author_sort | Szamosfalvi, Balazs |
collection | PubMed |
description | Continuous kidney replacement therapy (CKRT) can be a lifesaving intervention for critically ill patients; however, mortality remains high. The adaptation of existing innovations, including anti-clotting measures; cloud-computing for optimized treatment prescribing and therapy monitoring; and real-time sensing of blood and/or filter effluent composition to CKRT devices has the potential to enable personalized care and improve the safety and efficacy of this therapy. |
format | Online Article Text |
id | pubmed-7376311 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-73763112020-07-23 Innovations in CKRT: individualized therapy with fewer complications Szamosfalvi, Balazs Yessayan, Lenar Nat Rev Nephrol Comment Continuous kidney replacement therapy (CKRT) can be a lifesaving intervention for critically ill patients; however, mortality remains high. The adaptation of existing innovations, including anti-clotting measures; cloud-computing for optimized treatment prescribing and therapy monitoring; and real-time sensing of blood and/or filter effluent composition to CKRT devices has the potential to enable personalized care and improve the safety and efficacy of this therapy. Nature Publishing Group UK 2020-07-23 2020 /pmc/articles/PMC7376311/ /pubmed/32704048 http://dx.doi.org/10.1038/s41581-020-0326-1 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Comment Szamosfalvi, Balazs Yessayan, Lenar Innovations in CKRT: individualized therapy with fewer complications |
title | Innovations in CKRT: individualized therapy with fewer complications |
title_full | Innovations in CKRT: individualized therapy with fewer complications |
title_fullStr | Innovations in CKRT: individualized therapy with fewer complications |
title_full_unstemmed | Innovations in CKRT: individualized therapy with fewer complications |
title_short | Innovations in CKRT: individualized therapy with fewer complications |
title_sort | innovations in ckrt: individualized therapy with fewer complications |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376311/ https://www.ncbi.nlm.nih.gov/pubmed/32704048 http://dx.doi.org/10.1038/s41581-020-0326-1 |
work_keys_str_mv | AT szamosfalvibalazs innovationsinckrtindividualizedtherapywithfewercomplications AT yessayanlenar innovationsinckrtindividualizedtherapywithfewercomplications |